Lumida
/CWAN
⌘K
Clearwater Analytics Holdings Inc

Clearwater Analytics Holdings Inc

CWAN
$24.56USD+0.00%+0.00 today

MARKET CAP

7.3B

P/E (TTM)

FWD P/E

DAY RANGE

$25 – $25

52W RANGE

$25$25

AI Summary

Stalk
StalkMedium

CWAN remains in a Stage 2 advancing phase with an intact uptrend evidenced by higher highs and higher lows above rising EMAs, but price is currently churning around the 9- and 21-EMA cluster near mid-$24 resistance without clear momentum. Medium-term bias is bullish, supported by the HH+HL pattern and repaired moving averages, yet short-term timing is neutral; execution is deferred, stalking for a pullback into the rising EMA support zone for evidence of absorption before engaging.

  • Q2’25 revenue $181.9M (+70% YoY) and Q4’24 revenue $126.5M (+28% YoY) reflect strong top-line growth
  • ARR reached $783.5M (+83.4% YoY), driven by strong client retention and upsells
  • Valuation concerns due to weak earnings yield and low profitability indicators
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Clearwater Analytics (NASDAQ: CWAN) is a leading provider of investment management software and services. The company offers a robust cloud-native platform designed for institutional investors, focusing on enhancing operational efficiency through real-time data, regulatory compliance, and comprehensive reporting. Clearwater is positioned well within the investment management technology sector, targeting trends such as the digital transformation of financial services and the integration of generative AI into its solutions, thereby solidifying its competitive stance against traditional legacy systems.

Bull says

  • Q2’25 revenue $181.9M (+70% YoY) and Q4’24 revenue $126.5M (+28% YoY) reflect strong top-line growth
  • ARR reached $783.5M (+83.4% YoY), driven by strong client retention and upsells
  • 98% gross revenue retention and 110% net retention support recurring revenue stability
  • Integration of generative AI expected to improve margins and operational efficiency
  • $20M realized cost synergies from Infusion, Beacon, and Bistro acquisitions
  • Potential interest rate cuts could boost asset management activity and revenue

Bear says

  • Valuation concerns due to weak earnings yield and low profitability indicators
  • Insider sold $15.4M of stock, signaling potential lack of management confidence
  • Execution risk from integrating Infusion and Beacon may delay synergies
  • Revenue exposure to hedge funds and alternative assets creates market sensitivity
  • Regulatory adaptation challenges could impact client retention and compliance costs
  • Negative analyst revision sentiment and liquidity strain may pressure stock performance

Investment themes with CWAN

Software -1.57%

Cloud-based digital tools powering business productivity and innovation

MSFT · ORCL · PLTR

Earnings Call · Q3 2024 · Mgmt. Guidance

Updated 06-23-2026bullish

Transcript signals

Bull points

  • We continue to make solid progress on the growth initiatives we've been working on, and it's very rewarding to deliver these financial results.
  • Revenue for the quarter was $115.8 million, a 22.4% year-on-year increase.
  • Our annualized recurring revenue, ARR, grew by 26.1% year on year to $456.9 million.
Read full transcript analysis ›